ReadyRx GLP-1 prices
Telehealth where board-certified US physicians review each patient and prescribe compounded semaglutide and tirzepatide, with no membership fees. ReadyRx has 2 sourced self-pay GLP-1 offers here. Advertised entry prices: Compounded semaglutide $249/mo; Compounded tirzepatide $315/mo. Compounded products are not FDA-approved. Plan terms, fees and the check date are listed with each quote.
ReadyRx: prices at a glance
Compounded, not FDA-approved
Compounded semaglutide
$249/mo
Compounded, not FDA-approved
Compounded tirzepatide
$315/mo
Search by medication, provider or treatment goal. Examples follow.
2 offers · US self-pay · 2 maintenance quotes
- Advertised price$249/mo
Supply period unverified; excluded from cost ranking.
Checked
Maintenance price$249/moView offerAt 2.4 mg
Supply period unverified; excluded from cost ranking.
Checked
Price conditions & source
Advertised price: monthly plan, $229 the first month; the same price at every dose; no membership fees
Maintenance terms: The seller states one price at every dose, so this is also its price at 2.4 mg.
ReadyRx says "No membership fees" and "Same price at every dose". A ReadyRx landing page shows semaglutide at $159 first month then $199 a month; its treatment page shows these prices. It also offers quarterly plans whose prices are not shown in text. Compounded products are not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (readyrx.com) - Advertised price$315/mo
Supply period unverified; excluded from cost ranking.
Checked
Maintenance price$315/moView offerAt 15 mg
Supply period unverified; excluded from cost ranking.
Checked
Price conditions & source
Advertised price: monthly plan, $295 the first month; the same price at every dose; no membership fees
Maintenance terms: The seller states one price at every dose, so this is also its price at 15 mg.
ReadyRx says "No membership fees" and "Same price at every dose". A ReadyRx landing page shows semaglutide at $159 first month then $199 a month; its treatment page shows these prices. It also offers quarterly plans whose prices are not shown in text. Compounded products are not FDA-approved.
Confirm the prescribed dose, supply length, membership or consultation fees, and refill conditions with the provider. A listed offer does not confirm eligibility or stock.
Read the advertised-price source (readyrx.com)
Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.
Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.
The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of October 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.
ReadyRx GLP-1 cost: common questions
How much does semaglutide cost through ReadyRx?
Compounded semaglutide: $249/mo (monthly plan, $229 the first month; the same price at every dose; no membership fees). Checked Nov 6, 2026; each quote names its source in the table. Compounded semaglutide is not an FDA-approved product.
How much does tirzepatide cost through ReadyRx?
Compounded tirzepatide: $315/mo (monthly plan, $295 the first month; the same price at every dose; no membership fees). Checked Nov 6, 2026; each quote names its source in the table. Compounded tirzepatide is not an FDA-approved product.
Does ReadyRx offer FDA-approved GLP-1 medication or compounded versions?
The ReadyRx offers tracked here are compounded: Compounded semaglutide; Compounded tirzepatide. Compounded GLP-1s are not FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality.
Does ReadyRx charge a membership fee?
No membership fee is charged beside the price: ReadyRx's own pages say the price includes the clinician's care with the medication, for Compounded semaglutide; Compounded tirzepatide.
When were ReadyRx prices last checked?
Each quote carries its own check date and links the page it was read from: Nov 6, 2026 for the offers here. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.
What pharmacy does ReadyRx use?
ReadyRx's pages we read name no pharmacy. In its words: "Yes, all medications are sourced through FDA-registered, U.S.-based compounding pharmacies that follow strict regulatory and safety guidelines." Read Nov 6, 2026.
Are you ReadyRx? See how sellers are listed, how to correct a price, and the badge listed sellers can show.